Even after COVID-19 is controlled, climate change, growing resistance to antibiotics and lack of clean water will still be waiting for us. We need research that could change… everything. That’s what Blue Sky is all about.
Evolution provided bacteria with a mechanism to overcome our antibiotics, and each time we introduce a new antibiotic, they get faster at becoming resistant to it. At the same time, it can take 14 years and billions of dollars to bring a new one to market. Angela Violi, professor of mechanical engineering, is working to change the game by developing antibiotics in a new way. Her team wants to use machine learning to design nanoparticles that exploit weaknesses in the target pathogens. Not only could they work better, they could make it to market faster.
About the podcast: The Blue Sky podcast is a limited series from RE: Engineering Radio and the University of Michigan College of Engineering. It delves into the four research projects funded as part of the $6 million Blue Sky initiative. Launched in 2018, the initiative gives research teams the freedom to try daring ideas, show results and build momentum to secure further research investment in their efforts to solve global problems. Season 1 is an introduction to each project.